Swiss drugmaker Roche plans to complete its $4.3 billion takeover of gene therapy specialist Spark Therapeutics on Tuesday after U.S. and British authorities ruled the deal would not hurt competition in haemophilia A treatment.

Roche to complete $4.3 billion Spark deal as regulators give all clear

britains-competition-and-markets-authority

Britain's Competition And Markets Authority, News on Britain's Competition And Markets Authority, stories on Britain's Competition And Markets Authority, articles on Britain's Competition And Markets Authority, Britain's Competition And Markets Authority stories at Wion, Britain's Competition And Markets Authority news, Britain's Competition And Markets Authority latest news

britains competition-and-markets-authority

Roche to complete $4.3 billion Spark deal as regulators give all clear